Our findings indicate that anti-MDA5 IgG1 independently contributes to the risk of RP-ILD, underscoring the clinical importance of anti-MDA5 IgG subclasses in identifying high risk patients at an early stage. Here, IFIH1 is linked to retinitis pigmentosa 1.